{ "as_of": "2026-11-06", "cmr": "es-cm-kg/XMAD/ES0157261019", "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.", "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# LABORATORIOS FARMACEUTICOS ROVI S.A. (BME Madrid: ES0157261019) — research page\n\nAs of 2026-11-06 · es-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is LABORATORIOS FARMACEUTICOS ROVI S.A., listed on BME Madrid under ticker ES0157261019. Its ISIN is ES0157261019 and its LEI is 95980020140005936480. The security type, segment, sector and jurisdiction are not on the record. The issuer is listed and not halted.\n\n## The disclosure read\n\nThe record holds 25 filings in the twelve months to 2026-11-06, across 13 filing days. The median gap between filing days is 31.5 days. The latest filing is dated 2026-11-05 and is of type Sobre resultados, 1 day before the record date. The exchange median cadence gap is 9 days, the exchange median filings is 31.0, and the exchange median latency is 8 days. The sector median is not on the record.\n\n## Auditor\n\nThe auditor of record is not on the record, and neither is its location. The market's record does not carry auditor changes.\n\n## Events and halts\n\nThe record does not carry listing, delisting, name change, domicile change or segment move events for this market. The issuer is listed and not halted.\n\n## Orderability\n\nThe orderability outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/es/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names 10 research houses: Fidentis Equities, JB Capital Markets, Sabadell, Rx Securities, Kepler Cheuvreux, Intermoney Valores, Ahorro Corporación Financiera, BBVA, Exane BNP Paribas and La Caixa.\n\n## Open research\n\nNo openly published research notes were found on the pages read.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe vintage for this market is not sealed. The issuer has no sealed years on the record. The market's earliest sealed date is not on the record, and the live record began date is not on the record.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://firds.esma.europa.eu/firds/ (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.es-cm-kg.ai/events/XMAD/ES0157261019 (the disclosure lines)\n- https://www.cnmv.es/portal/Informacion-Privilegiada/Resultado-IP?tipos=&fechaDesde=09/11/2025&fechaHasta=09/11/2026 | https://www.cnmv.es/portal/Otra-Informacion-Relevante/Resultado-OIR?tipos=&fechaDesde=09/11/2025&fechaHasta=09/11/2026 | https://apiweb.bolsasymercados.es/Market/v1/EQ/ShareDetailsInfo?isin= (the halt flag)\n- https://es.eu-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://rovi.es/uk/en/cobertura-por-analistas (coverage)\n- https://mcp.es-cm-kg.ai/record/XMAD/ES0157261019 (the record)\n", "market": "ES", "node": "es-cm-kg", "numbers": { "as_of_depth": { "issuer_years_sealed": [], "live_record_began": null, "node_history_from": null, "node_years_sealed": [], "note": "the ES vintage is not sealed; the record is the live record as of 2026-11-06", "record_version": 1, "sealed": false }, "auditor": { "auditor": { "market": "ES", "state": "not_on_record" }, "auditor_firm_id": { "market": "ES", "state": "not_on_record" }, "auditor_location": { "market": "ES", "state": "not_on_record" }, "changes": { "market": "ES", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" } }, "cmr": "es-cm-kg/XMAD/ES0157261019", "coverage": { "count": 10, "houses": [ { "analyst": "Patricia Cifuentes", "house": "Fidentis Equities", "read_by": "issuer IR page, fetched by this rail; each house name read on the page", "read_date": "2026-11-12", "source": "https://rovi.es/uk/en/cobertura-por-analistas", "state": "sourced" }, { "analyst": "César Gonzalez", "house": "JB Capital Markets", "read_by": "issuer IR page, fetched by this rail; each house name read on the page", "read_date": "2026-11-12", "source": "https://rovi.es/uk/en/cobertura-por-analistas", "state": "sourced" }, { "analyst": "Felipe Echevarría", "house": "Sabadell", "read_by": "issuer IR page, fetched by this rail; each house name read on the page", "read_date": "2026-11-12", "source": "https://rovi.es/uk/en/cobertura-por-analistas", "state": "sourced" }, { "analyst": "Samir Devani", "house": "Rx Securities", "read_by": "issuer IR page, fetched by this rail; each house name read on the page", "read_date": "2026-11-12", "source": "https://rovi.es/uk/en/cobertura-por-analistas", "state": "sourced" }, { "analyst": "Natalia Bobo", "house": "Kepler Cheuvreux", "read_by": "issuer IR page, fetched by this rail; each house name read on the page", "read_date": "2026-11-12", "source": "https://rovi.es/uk/en/cobertura-por-analistas", "state": "sourced" }, { "analyst": "Elena Fernández", "house": "Intermoney Valores", "read_by": "issuer IR page, fetched by this rail; each house name read on the page", "read_date": "2026-11-12", "source": "https://rovi.es/uk/en/cobertura-por-analistas", "state": "sourced" }, { "analyst": "Álvaro Arístegui", "house": "Ahorro Corporación Financiera", "read_by": "issuer IR page, fetched by this rail; each house name read on the page", "read_date": "2026-11-12", "source": "https://rovi.es/uk/en/cobertura-por-analistas", "state": "sourced" }, { "analyst": "Isabel Carballo", "house": "BBVA", "read_by": "issuer IR page, fetched by this rail; each house name read on the page", "read_date": "2026-11-12", "source": "https://rovi.es/uk/en/cobertura-por-analistas", "state": "sourced" }, { "analyst": "Francisco Ruiz Martín", "house": "Exane BNP Paribas", "read_by": "issuer IR page, fetched by this rail; each house name read on the page", "read_date": "2026-11-12", "source": "https://rovi.es/uk/en/cobertura-por-analistas", "state": "sourced" }, { "analyst": "Jose María Cánovas", "house": "La Caixa", "read_by": "issuer IR page, fetched by this rail; each house name read on the page", "read_date": "2026-11-12", "source": "https://rovi.es/uk/en/cobertura-por-analistas", "state": "sourced" } ], "pages_checked": [ { "page": "https://rovi.es/uk/en/cobertura-por-analistas", "result": "read: 10 of 17 named houses found on the page" } ], "read_by": "Perplexity sonar (search) · page read by this rail", "read_date": "2026-11-12", "since": "not stated on the page read", "state": "found" }, "disclosure": { "against": { "exchange": { "issuers": 122, "median_cadence_gap_days": 9, "median_filings": 31, "median_latency_days": 8, "name": "BME Madrid" }, "sector": { "market": "ES", "state": "not_on_record" } }, "by_type": { "Contratos de liquidez y contrapartida": 4, "Convocatoria de Junta o Asamblea": 2, "Informe anual de gobierno corporativo": 1, "Informe anual de remuneraciones de los consejeros": 1, "Informes financieros anuales y de auditoría": 1, "Informes financieros semestrales y de auditoría / revisiones limitadas": 2, "Otra información relevante": 1, "Sobre gobierno corporativo": 1, "Sobre negocio y situación financiera": 2, "Sobre operaciones corporativas": 1, "Sobre resultados": 9 }, "cadence_median_gap_days": 31.5, "filing_days": 13, "filings": 25, "latency_days": 1, "latest": [ { "category": "Sobre resultados", "date": "2026-11-05", "source": "https://www.cnmv.es/webservices/verdocumento/ver?t=%7b91584812-df97-4591-b9a7-17b47ac5f66b%7d", "title": "La Compañía hace pública la presentación relativa a los resultados financieros de los primeros nueve meses de 2026", "type": "Sobre resultados" }, { "category": "Sobre resultados", "date": "2026-11-05", "source": "https://www.cnmv.es/webservices/verdocumento/ver?t=%7b6e5edc70-cb3f-4757-ae95-74fb9a2ce230%7d", "title": "La Compañía hace público el comunicado de prensa relativo a los resultados financieros de los primeros nueve meses de 2026", "type": "Sobre resultados" }, { "category": "Contratos de liquidez y contrapartida", "date": "2026-10-02", "source": "https://www.cnmv.es/webservices/verdocumento/ver?t=%7b873a29f5-7048-49a2-b025-9d8f7ad280b8%7d", "title": "Operaciones sobre acciones propias efectuadas en el tercer trimestre de 2026 en el marco del contrato de liquidez", "type": "Contratos de liquidez y contrapartida" }, { "category": "Sobre resultados", "date": "2026-07-23", "source": "https://www.cnmv.es/webservices/verdocumento/ver?t=%7bea0cbea3-ddd1-4d59-8429-b65092dd2ba7%7d", "title": "La Compañía hace público el comunicado de prensa relativo a los resultados financieros del primer semestre de 2026", "type": "Sobre resultados" }, { "category": "Sobre resultados", "date": "2026-07-23", "source": "https://www.cnmv.es/webservices/verdocumento/ver?t=%7b1097f2cf-e845-46bb-a4b4-44da60e5414a%7d", "title": "La Compañía hace pública la presentación relativa a los resultados financieros del primer semestre de 2026", "type": "Sobre resultados" } ], "latest_filing_date": "2026-11-05", "read": "the node's event lines (list_events_since), as get_filings serves them", "source": "https://mcp.es-cm-kg.ai/events/XMAD/ES0157261019", "window": { "from": "2025-11-06", "to": "2026-11-06" } }, "identity": { "exchange": { "read_by": "allooloo-cm-kg/eu-sources/es roster.py", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)", "state": "sourced", "value": "BME Madrid" }, "isin": { "read_by": "allooloo-cm-kg/eu-sources/es roster.py", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)", "state": "sourced", "value": "ES0157261019" }, "jurisdiction": { "market": "ES", "state": "not_on_record" }, "lei": { "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN", "read_date": "2026-11-09", "read_date_basis": "the field", "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN ES0157261019)", "state": "sourced", "value": "95980020140005936480" }, "name": { "read_by": "allooloo-cm-kg/eu-sources/es roster.py", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)", "state": "sourced", "value": "LABORATORIOS FARMACEUTICOS ROVI S.A." }, "sector": { "market": "ES", "state": "not_on_record" }, "security_type": { "market": "ES", "state": "not_on_record" }, "segment": { "market": "ES", "state": "not_on_record" }, "ticker": { "read_by": "allooloo-cm-kg/eu-sources/es roster.py", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)", "state": "sourced", "value": "ES0157261019" }, "website": { "market": "ES", "state": "not_on_record" } }, "licensed": { "columns": [ "licensor", "entitlement", "title", "date", "source" ], "rows": [], "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded." }, "lifecycle": { "delisting": { "market": "ES", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" }, "domicile_change": { "market": "ES", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" }, "listing": { "market": "ES", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" }, "name_change": { "market": "ES", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" }, "segment_move": { "market": "ES", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" } }, "market": "ES", "node": "es-cm-kg", "numbers_hash": "sha256:a3190300f3196324bff6408053cce648f59f289b1902b018e19dde0a2b2f04b8", "open_research": { "read_date": "2026-11-12", "rows": [], "state": "none_found" }, "orderability": { "chapter_as_of": "2026-11-04", "client_categories": [], "determinable": false, "read": { "chapter": "https://es.eu-cm-kg.ai/book/aio.json", "door": "https://es.eu-cm-kg.ai/mcp", "tool": "get_orderability" }, "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category", "rule_version": "acm-68000/es/mifid-ii-product-governance/r1", "section": "es.aio.v6" }, "record": { "as_of": "2026-11-06", "url": "https://mcp.es-cm-kg.ai/record/XMAD/ES0157261019", "version": 1 }, "schema": "research-numbers v0.1 (USR-01, 2026-11-11)", "status": { "read_date": "2026-11-09", "source": "https://www.cnmv.es/portal/Informacion-Privilegiada/Resultado-IP?tipos=&fechaDesde=09/11/2025&fechaHasta=09/11/2026 | https://www.cnmv.es/portal/Otra-Informacion-Relevante/Resultado-OIR?tipos=&fechaDesde=09/11/2025&fechaHasta=09/11/2026 | https://apiweb.bolsasymercados.es/Market/v1/EQ/ShareDetailsInfo?isin=", "value": "listed, not halted" } }, "numbers_hash": "sha256:a3190300f3196324bff6408053cce648f59f289b1902b018e19dde0a2b2f04b8", "path": "/es/XMAD/ES0157261019", "schema": "research-page v0.1 (USR-02, 2026-11-11)", "sections": [ { "id": "identity", "text": "The issuer is LABORATORIOS FARMACEUTICOS ROVI S.A., listed on BME Madrid under ticker ES0157261019. Its ISIN is ES0157261019 and its LEI is 95980020140005936480. The security type, segment, sector and jurisdiction are not on the record. The issuer is listed and not halted.", "title": "Identity and listing" }, { "id": "disclosure", "text": "The record holds 25 filings in the twelve months to 2026-11-06, across 13 filing days. The median gap between filing days is 31.5 days. The latest filing is dated 2026-11-05 and is of type Sobre resultados, 1 day before the record date. The exchange median cadence gap is 9 days, the exchange median filings is 31.0, and the exchange median latency is 8 days. The sector median is not on the record.", "title": "The disclosure read" }, { "id": "auditor", "text": "The auditor of record is not on the record, and neither is its location. The market's record does not carry auditor changes.", "title": "Auditor" }, { "id": "events", "text": "The record does not carry listing, delisting, name change, domicile change or segment move events for this market. The issuer is listed and not halted.", "title": "Events and halts" }, { "id": "orderability", "text": "The orderability outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/es/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.", "title": "Orderability" }, { "id": "coverage", "text": "The issuer's investor-relations page names 10 research houses: Fidentis Equities, JB Capital Markets, Sabadell, Rx Securities, Kepler Cheuvreux, Intermoney Valores, Ahorro Corporación Financiera, BBVA, Exane BNP Paribas and La Caixa.", "title": "Coverage" }, { "id": "open_research", "text": "No openly published research notes were found on the pages read.", "title": "Open research" }, { "id": "licensed", "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.", "title": "Licensed" }, { "id": "depth", "text": "The vintage for this market is not sealed. The issuer has no sealed years on the record. The market's earliest sealed date is not on the record, and the live record began date is not on the record.", "title": "As-of depth" }, { "id": "sources", "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.", "title": "Sources" } ], "sources": [ { "for": "identity.exchange", "source": "https://firds.esma.europa.eu/firds/" }, { "for": "identity.lei", "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download" }, { "for": "the disclosure lines", "source": "https://mcp.es-cm-kg.ai/events/XMAD/ES0157261019" }, { "for": "the halt flag", "source": "https://www.cnmv.es/portal/Informacion-Privilegiada/Resultado-IP?tipos=&fechaDesde=09/11/2025&fechaHasta=09/11/2026 | https://www.cnmv.es/portal/Otra-Informacion-Relevante/Resultado-OIR?tipos=&fechaDesde=09/11/2025&fechaHasta=09/11/2026 | https://apiweb.bolsasymercados.es/Market/v1/EQ/ShareDetailsInfo?isin=" }, { "for": "the orderability chapter", "source": "https://es.eu-cm-kg.ai/book/aio.json" }, { "for": "coverage", "source": "https://rovi.es/uk/en/cobertura-por-analistas" }, { "for": "the record", "source": "https://mcp.es-cm-kg.ai/record/XMAD/ES0157261019" } ], "title": "LABORATORIOS FARMACEUTICOS ROVI S.A. (ES0157261019) — research page", "writer": { "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers", "engine": "claude-haiku-5-5" } }